SunBio선바이오
067370 · KOSDAQ · ₩067370 · 선바이오
₩5,250▼ ₩280 (5.06%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Gross margin | 60.5% | 61.0% | 68.2% | 70.3% | 60.8% |
| Operating margin | 35.9% | 36.8% | −6.1% | 42.2% | 2.6% |
| Net margin | 34.6% | 20.4% | −1.2% | 37.5% | 11.7% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue growth | −8.9% | +57.5% | −29.4% | +65.7% | — |
| Operating income growth | −11.2% | +1,044.4% | −110.3% | +2,619.8% | — |
| Net income growth | +54.4% | +2,776.2% | −102.3% | +429.9% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Return on equity | 14.7% | 10.0% | −0.4% | 17.7% | 3.6% |
| Return on assets | 6.9% | 4.6% | −0.2% | 10.2% | 2.0% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Liabilities to equity | 114.2% | 110.2% | 125.3% | 69.6% | 79.9% |
| Net debt to equity | 84.9% | 54.2% | 29.1% | 36.5% | 66.7% |
| Current ratio | 45.6% | 53.0% | 71.8% | 65.4% | 89.3% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: SunBio / 선바이오 / 067370 / KRX:067370
Source: KRX statistical information